Increasingly, genomics studies of breast tumours in Asian women suggest that they have a distinct molecular profile as well, with a more active immune microenvironment and higher frequencies of TP53 somatic mutations compared to Caucasian women [13, 29, 41, 42]. This evidence concerns the gene TP53 and breast neoplasm.